Asivatrep, a TRPV1 antagonist, for the topical treatment of atopic dermatitis: Phase 3, randomized, vehicle-controlled study (CAPTAIN-AD)
Park, C. W., Park, M., 김규한, Kim, B. J., Lee, Y. W., Won, C., Park, C. O., Chung, B. Y., 이동훈, Jung, K., Nam, H. J., Choi, G., Park, Y. H.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 202204